Actinium Pharmaceuticals Inc (NYSE American:ATNM)
| 7.17 BATS BZX Real-Time Price As of Nov 30 |  0.00 / 0.00%Today’s Change | 5.70 Today|||52-Week Range 11.90 | -8.08% Year-to-Date |
Latest ATNM News | Press Releases
No recent news for Actinium Pharmaceuticals Inc.
Today’s Trading
| Previous close | 7.17 |
| Today’s open | 7.34 |
| Day’s range | 6.64 - 7.17 |
| Volume | 16,137 |
| Average volume (3 months) | 203,440 |
| Market cap | $160.8M |
Data as of 4:00pm ET, 11/30/2021
Growth & Valuation
| Earnings growth (last year) | +58.40% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | +2.00% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 2.08 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| CRVSCorvus Pharmaceutica... | +0.08 | +2.34% |
| MNOVMediciNova Inc | +0.01 | +0.31% |
| RDHLRedhill Biopharma Lt... | +0.03 | +1.03% |
| KLDOKaleido Biosciences ... | +0.03 | +0.84% |
Data as of 10:26am ET, 12/01/2021
Financials
| Next reporting date | March 18, 2022 |
| EPS forecast (this quarter) | -$0.28 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$22.2M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters New York, New York |
Forecasts
